Evelyn Partners Investment Management LLP Invests $3.25 Million in Marsh & McLennan Companies, Inc. $MRSH

Evelyn Partners Investment Management LLP purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 17,495 shares of the financial services provider’s stock, valued at approximately $3,246,000.

Several other institutional investors have also modified their holdings of MRSH. Numerai GP LLC raised its holdings in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after buying an additional 33,729 shares during the period. Swiss Life Asset Management Ltd raised its holdings in Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after buying an additional 11,648 shares during the period. Barclays PLC raised its holdings in Marsh & McLennan Companies by 41.7% in the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after buying an additional 647,987 shares during the period. Sarasin & Partners LLP raised its holdings in Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after buying an additional 8,283 shares during the period. Finally, Brown Brothers Harriman & Co. raised its holdings in Marsh & McLennan Companies by 26.4% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock valued at $27,444,000 after buying an additional 28,419 shares during the period. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of Marsh & McLennan Companies stock opened at $168.67 on Friday. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $220.32. The stock has a market cap of $81.49 billion, a PE ratio of 21.08, a P/E/G ratio of 2.46 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last announced its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies’s revenue was up 7.6% compared to the same quarter last year. As a group, equities research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Wall Street Analyst Weigh In

MRSH has been the topic of several research analyst reports. Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. JPMorgan Chase & Co. dropped their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research report on Thursday, April 9th. Barclays dropped their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. UBS Group dropped their target price on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research report on Tuesday, June 9th. Finally, Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a research report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and an average target price of $200.19.

Check Out Our Latest Report on MRSH

Insider Activity at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Stories

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.